Ophthalmic composition comprising diquafosol and cationic polymer
MYPI2026002574A0Undetermined Publication Date: 2019-08-28SANTEN PHARMACEUTICAL CO LTD
0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2026002574
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2018-02-28
- Filing Date
- 2026-04-28
- Publication Date
- 2019-08-28
Abstract
Provided is an ophthalmic composition comprising diquafosol or a salt thereof and a cationic polymer, the cationic polymer being at least one selected from the group consisting of chitosan, a chitosan derivative, a cationic (meth)acrylate copolymer, a cationic silicone polymer, a diallyl quaternary ammonium salt-acrylamide copolymer, cationic hydrolyzed keratin, cationic hydrolyzed silk, cationic hydrolyzed collagen, cationic hydrolyzed casein, cationic hydrolyzed soy protein, a cationic vinylpyrrolidone copolymer, polyvinylpyrrolidone, a dimethyldiacrylammonium chloride homopolymer, an adipic acid-dimethylaminohydroxypropyldiethylenetriamine copolymer, an adipic acid-epoxypropyldiethylenetriamine copolymer and an acrylamide--methacryloyloxyethyltrimethylammoniummethyl sulfate copolymer.
Need to check novelty before this filing date? Find Prior Art
